Potential of Biomaterials in Advancing Neuroprotection

References

1. MukherjeeS. MadamsettyV.S. BhattacharyaD. Roy ChowdhuryS. PaulM.K. MukherjeeA. Recent advancements of nanomedicine in neurodegenerative disorders theranostics.Adv. Funct. Mater.20203035200305410.1002/adfm.202003054
   [Google Scholar]
2. OriveG. AnituaE. PedrazJ.L. EmerichD.F. Biomaterials for promoting brain protection, repair and regeneration.Nat. Rev. Neurosci.200910968269210.1038/nrn268519654582
   [Google Scholar]
3. PalocziJ. VargaZ.V. HaskoG. PacherP. Neuroprotection in oxidative stress-related neurodegenerative diseases: Role of endocannabinoid system modulation.Antioxid. Redox Signal.20182917510810.1089/ars.2017.714428497982
   [Google Scholar]
4. KimH. CookeM.J. ShoichetM.S. Creating permissive microenvironments for stem cell transplantation into the central nervous system.Trends Biotechnol.2012301556310.1016/j.tibtech.2011.07.00221831464
   [Google Scholar]
5. LiJ. MooneyD.J. Designing hydrogels for controlled drug delivery.Nat. Rev. Mater.20161121607110.1038/natrevmats.2016.7129657852
   [Google Scholar]
6. EchaveM.C. Saenz del BurgoL. PedrazJ.L. OriveG. Gelatin as biomaterial for tissue engineering.Curr. Pharm. Des.201723243567358428494717
   [Google Scholar]
7. GoriM. VadalàG. GiannitelliS.M. DenaroV. Di PinoG. Biomedical and tissue engineering strategies to control foreign body reaction to invasive neural electrodes.Front. Bioeng. Biotechnol.2021965903310.3389/fbioe.2021.65903334113605
   [Google Scholar]
8. LacourS.P. CourtineG. GuckJ. Materials and technologies for soft implantable neuroprostheses.Nat. Rev. Mater.20161101606310.1038/natrevmats.2016.63
   [Google Scholar]
9. ManjiH.K. QuirozJ.A. SpornJ. PayneJ.L. DenicoffK. A GrayN. ZarateC.A.Jr CharneyD.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.Biol. Psychiatry200353870774210.1016/S0006‑3223(03)00117‑312706957
   [Google Scholar]
10. TakeshitaY. RansohoffR.M. Inflammatory cell trafficking across the blood–brain barrier: Chemokine regulation and in vitro models.Immunol. Rev.2012248122823910.1111/j.1600‑065X.2012.01127.x22725965
    [Google Scholar]
11. TeixeiraM.I. LopesC.M. AmaralM.H. CostaP.C. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.Eur. J. Pharm. Biopharm.202014919221710.1016/j.ejpb.2020.01.00531982574
    [Google Scholar]
12. GreeneC. CampbellM. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.Tissue Barriers201641e113801710.1080/21688370.2015.113801727141420
    [Google Scholar]
13. BarbuE. MolnàrÉ. TsibouklisJ. GóreckiD.C. The potential for nanoparticle-based drug delivery to the brain: Overcoming the blood–brain barrier.Expert Opin. Drug Deliv.20096655356510.1517/1742524090293914319435406
    [Google Scholar]
14. Salahpour AnarjanF. Active targeting drug delivery nanocarriers: Ligands.Nano-Struct. Nano-Objects20191910037010.1016/j.nanoso.2019.100370
    [Google Scholar]
15. DingS. KhanA.I. CaiX. SongY. LyuZ. DuD. DuttaP. LinY. Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.Mater. Today20203711212510.1016/j.mattod.2020.02.00133093794
    [Google Scholar]
16. LaracuenteM.L. YuM.H. McHughK.J. Zero-order drug delivery: State of the art and future prospects.J. Control. Release202032783485610.1016/j.jconrel.2020.09.02032931897
    [Google Scholar]
17. ChenZ. LvZ. SunY. ChiZ. QingG. Recent advancements in polyethyleneimine-based materials and their biomedical, biotechnology, and biomaterial applications.J. Mater. Chem. B Mater. Biol. Med.20208152951297310.1039/C9TB02271F32159205
    [Google Scholar]
18. DanhierF. AnsorenaE. SilvaJ.M. CocoR. Le BretonA. PréatV. PLGA-based nanoparticles: An overview of biomedical applications.J. Control. Release2012161250552210.1016/j.jconrel.2012.01.04322353619
    [Google Scholar]
19. MohiteP.B. AdhavS.S. A hydrogels: Methods of preparation and applications.Int. J. Adv. Pharm.2017637985
    [Google Scholar]
20. PrankeP. dos SantosM.G. PrestesJ.P. Nanopolymers: Powerful tools in neuroprotection and neuroregeneration.Curr. Nanosci.202218666867410.2174/1573413718666211217123809
    [Google Scholar]
21. NanceE. PunS.H. SaigalR. SellersD.L. Drug delivery to the central nervous system.Nat. Rev. Mater.20217431433110.1038/s41578‑021‑00394‑w
    [Google Scholar]
22. LiuZ. WanX. WangZ.L. LiL. Electroactive biomaterials and systems for cell fate determination and tissue regeneration: Design and applications.Adv. Mater.20213332200742910.1002/adma.20200742934117803
    [Google Scholar]
23. ShanD. MaC. YangJ. Enabling biodegradable functional biomaterials for the management of neurological disorders.Adv. Drug Deliv. Rev.201914821923810.1016/j.addr.2019.06.00431228483
    [Google Scholar]
24. BoniR. AliA. ShavandiA. ClarksonA.N. Current and novel polymeric biomaterials for neural tissue engineering.J. Biomed. Sci.20182519010.1186/s12929‑018‑0491‑830572957
    [Google Scholar]
25. KaurG. AdhikariR. CassP. BownM. GunatillakeP. Electrically conductive polymers and composites for biomedical applications.RSC Advances2015547375533756710.1039/C5RA01851J
    [Google Scholar]
26. LuoY. YangH. ZhouY.F. HuB. Dual and multi-targeted nanoparticles for site-specific brain drug delivery.J. Control. Release202031719521510.1016/j.jconrel.2019.11.03731794799
    [Google Scholar]
27. ManoukianO.S. BakerJ.T. RudraiahS. ArulM.R. VellaA.T. DombA.J. KumbarS.G. Functional polymeric nerve guidance conduits and drug delivery strategies for peripheral nerve repair and regeneration.J. Control. Release2020317789510.1016/j.jconrel.2019.11.02131756394
    [Google Scholar]
28. González-NietoD. Fernández-SerraR. Pérez-RigueiroJ. PanetsosF. Martinez-MurilloR. GuineaG.V. Biomaterials to neuroprotect the stroke brain: A large opportunity for narrow time windows.Cells202095107410.3390/cells905107432357544
    [Google Scholar]
29. SalinasA.J. Vallet-RegíM. Bioactive ceramics: From bone grafts to tissue engineering.RSC Advances2013328111161113110.1039/c3ra00166k
    [Google Scholar]
30. SpeerR.E. KaruppagounderS.S. BassoM. SleimanS.F. KumarA. BrandD. SmirnovaN. GazaryanI. KhimS.J. RatanR.R. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by “antioxidant” metal chelators: From ferroptosis to stroke.Free Radic. Biol. Med.201362263610.1016/j.freeradbiomed.2013.01.02623376032
    [Google Scholar]
31. González-NietoD. Fernandez-SerraR. GallegoR. LozanoP. Hydrogels for neuroprotection and functional rewiring: A new era for brain engineering.Neural Regen. Res.202015578378910.4103/1673‑5374.26889131719237
    [Google Scholar]
32. SiddiqiK.S. HusenA. SohrabS.S. YassinM.O. Recent status of nanomaterial fabrication and their potential applications in neurological disease management.Nanoscale Res. Lett.201813123110.1186/s11671‑018‑2638‑730097809
    [Google Scholar]
33. ChenJ. JinJ. LiK. ShiL. WenX. FangF. Progresses and prospects of neuroprotective agents-loaded nanoparticles and biomimetic material in ischemic stroke.Front. Cell. Neurosci.20221686832310.3389/fncel.2022.86832335480961
    [Google Scholar]
34. PakulskaM.M. BalliosB.G. ShoichetM.S. Injectable hydrogels for central nervous system therapy.Biomed. Mater.20127202410110.1088/1748‑6041/7/2/02410122456684
    [Google Scholar]
35. MohtaramN.K. MontgomeryA. WillerthS.M. Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors.Biomed. Mater.20138202200110.1088/1748‑6041/8/2/02200123385544
    [Google Scholar]
36. KimY.S. MajidM. MelchiorriA.J. MikosA.G. Applications of decellularized extracellular matrix in bone and cartilage tissue engineering.Bioeng. Transl. Med.201941839510.1002/btm2.1011030680321
    [Google Scholar]
37. SushnithaM. EvangelopoulosM. TasciottiE. TaraballiF. Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications.Front. Bioeng. Biotechnol.2020862710.3389/fbioe.2020.0062732626700
    [Google Scholar]
38. YaoY. ZhangH. WangZ. DingJ. WangS. HuangB. KeS. GaoC. Reactive oxygen species (ROS)-responsive biomaterials mediate tissue microenvironments and tissue regeneration.J. Mater. Chem. B Mater. Biol. Med.20197335019503710.1039/C9TB00847K31432870
    [Google Scholar]
39. RatheeshG. VenugopalJ.R. ChinappanA. EzhilarasuH. SadiqA. RamakrishnaS. 3D fabrication of polymeric scaffolds for regenerative therapy.ACS Biomater. Sci. Eng.2017371175119410.1021/acsbiomaterials.6b0037033440508
    [Google Scholar]
40. ChengJ. JunY. QinJ. LeeS.H. Electrospinning versus microfluidic spinning of functional fibers for biomedical applications.Biomaterials201711412114310.1016/j.biomaterials.2016.10.04027880892
    [Google Scholar]
41. GuzziE.A. TibbittM.W. Additive manufacturing of precision biomaterials.Adv. Mater.20203213190199410.1002/adma.20190199431423679
    [Google Scholar]
42. XieJ. MacEwanM.R. SchwartzA.G. XiaY. Electrospun nanofibers for neural tissue engineering.Nanoscale201021354410.1039/B9NR00243J20648362
    [Google Scholar]
43. NagarajanN. Dupret-BoriesA. KarabulutE. ZorlutunaP. VranaN.E. Enabling personalized implant and controllable biosystem development through 3D printing.Biotechnol. Adv.201836252153310.1016/j.biotechadv.2018.02.00429428560
    [Google Scholar]
44. NaqviS. PanghalA. FloraS.J.S. Nanotechnology: A promising approach for delivery of neuroprotective drugs.Front. Neurosci.20201449410.3389/fnins.2020.0049432581676
    [Google Scholar]
45. SaracinoG.A.A. CigogniniD. SilvaD. CapriniA. GelainF. Nanomaterials design and tests for neural tissue engineering.Chem. Soc. Rev.201342122526210.1039/C2CS35065C22990473
    [Google Scholar]
46. WadeR.J. BurdickJ.A. Engineering ECM signals into biomaterials.Mater. Today2012151045445910.1016/S1369‑7021(12)70197‑9
    [Google Scholar]
47. BasakS. The age of multistimuli-responsive nanogels: The finest evolved nano delivery system in biomedical sciences.Biotechnol. Bioprocess Eng.; BBE202025565566910.1007/s12257‑020‑0152‑0
    [Google Scholar]
48. ZhaoZ. UkidveA. KimJ. MitragotriS. Targeting strategies for tissue-specific drug delivery.Cell2020181115116710.1016/j.cell.2020.02.00132243788
    [Google Scholar]
49. geor malarC. SeenuvasanM. KumarK.S. KumarA. ParthibanR. Review on surface modification of nanocarriers to overcome diffusion limitations: An enzyme immobilization aspect.Biochem. Eng. J.202015810757410.1016/j.bej.2020.107574
    [Google Scholar]
50. UhrichK.E. CannizzaroS.M. LangerR.S. ShakesheffK.M. Polymeric systems for controlled drug release.Chem. Rev.199999113181319810.1021/cr940351u11749514
    [Google Scholar]
51. UllahS. ChenX. Fabrication, applications and challenges of natural biomaterials in tissue engineering.Appl. Mater. Today20202010065610.1016/j.apmt.2020.100656
    [Google Scholar]
52. GillespieL.N. Regulation of axonal growth and guidance by the neurotrophin family of neurotrophic factors.Clin. Exp. Pharmacol. Physiol.2003301072473310.1046/j.1440‑1681.2003.03909.x14516410
    [Google Scholar]
53. AminiS. SalehiH. SetayeshmehrM. GhorbaniM. Natural and synthetic polymeric scaffolds used in peripheral nerve tissue engineering: Advantages and disadvantages.Polym. Adv. Technol.20213262267228910.1002/pat.5263
    [Google Scholar]
54. MitchellA.C. BriquezP.S. HubbellJ.A. CochranJ.R. Engineering growth factors for regenerative medicine applications.Acta Biomater.20163011210.1016/j.actbio.2015.11.00726555377
    [Google Scholar]
55. KimS.U. LeeH.J. KimY.B. Neural stem cell‐based treatment for neurodegenerative diseases.Neuropathology201333549150410.1111/neup.1202023384285
    [Google Scholar]
56. CaiadoF. DiasS. Endothelial progenitor cells and integrins: Adhesive needs.Fibrog. Tissue Repair201251410.1186/1755‑1536‑5‑422410175
    [Google Scholar]
57. VaesJ.E.G. BrandtM.J.V. WandersN. BendersM.J.N.L. de TheijeC.G.M. GressensP. NijboerC.H. The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.Glia20216961311134010.1002/glia.2393933595855
    [Google Scholar]
58. ZischA.H. LutolfM.P. HubbellJ.A. Biopolymeric delivery matrices for angiogenic growth factors.Cardiovasc. Pathol.200312629531010.1016/S1054‑8807(03)00089‑914630296
    [Google Scholar]
59. RhamanM.M. IslamM.R. AkashS. MimM. Noor alamM. NepovimovaE. ValisM. KucaK. SharmaR. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance.Front. Cell Dev. Biol.20221098947110.3389/fcell.2022.98947136120565
    [Google Scholar]
60. GuX. DingF. WilliamsD.F. Neural tissue engineering options for peripheral nerve regeneration.Biomaterials201435246143615610.1016/j.biomaterials.2014.04.06424818883
    [Google Scholar]
61. ChenM. Recent advances and perspective of nanotechnology-based implants for orthopedic applications.Front. Bioeng. Biotechnol.20221087825710.3389/fbioe.2022.87825735547165
    [Google Scholar]
62. UzM. MallapragadaS.K. Conductive polymers and hydrogels for neural tissue engineering.J. Indian Inst. Sci.201999348951010.1007/s41745‑019‑00126‑8
    [Google Scholar]
63. AngiusD. WangH. SpinnerR.J. Gutierrez-CottoY. YaszemskiM.J. WindebankA.J. A systematic review of animal models used to study nerve regeneration in tissue-engineered scaffolds.Biomaterials201233328034803910.1016/j.biomaterials.2012.07.05622889485
    [Google Scholar]
64. KwonB.K. OkonE.B. TsaiE. BeattieM.S. BresnahanJ.C. MagnusonD.K. ReierP.J. McTigueD.M. PopovichP.G. BlightA.R. OudegaM. GuestJ.D. WeaverL.C. FehlingsM.G. TetzlaffW. A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.J. Neurotrauma20112881525154310.1089/neu.2010.129620507235
    [Google Scholar]
65. CernakI. SteinD.G. ElderG.A. AhlersS. CurleyK. DePalmaR.G. DudaJ. IkonomovicM. IversonG.L. KobeissyF. KoliatsosV.E. LeggieriM.J.Jr PacificoA.M. SmithD.H. SwansonR. ThompsonF.J. TortellaF.C. Preclinical modelling of militarily relevant traumatic brain injuries: Challenges and recommendations for future directions.Brain Inj.20173191168117610.1080/02699052.2016.127477928981339
    [Google Scholar]
66. MorettiA. FerrariF. VillaR.F. Neuroprotection for ischaemic stroke: Current status and challenges.Pharmacol. Ther.2015146233410.1016/j.pharmthera.2014.09.00325196155
    [Google Scholar]
67. PuzzoD. LeeL. PalmeriA. CalabreseG. ArancioO. Behavioral assays with mouse models of Alzheimer’s disease: Practical considerations and guidelines.Biochem. Pharmacol.201488445046710.1016/j.bcp.2014.01.01124462904
    [Google Scholar]
68. EbertM.L.A. SchmidtV.F. PfaffL. von ThadenA. KimmM.A. WildgruberM. Animal models of neointimal hyperplasia and restenosis: Species-specific differences and implications for translational research.JACC Basic Transl. Sci.202161190091710.1016/j.jacbts.2021.06.00634869956
    [Google Scholar]
69. LiH.W. ZhangL. QinC. Current state of research on non‐human primate models of Alzheimer’s disease.Animal Model. Exp. Med.20192422723810.1002/ame2.1209231942555
    [Google Scholar]
70. BassoM.A. FreyS. GuerrieroK.A. JarrayaB. KastnerS. KoyanoK.W. LeopoldD.A. MurphyK. PoirierC. PopeW. SilvaA.C. TanseyG. UhrigL. Using non-invasive neuroimaging to enhance the care, well-being and experimental outcomes of laboratory non-human primates (monkeys).Neuroimage202122811766710.1016/j.neuroimage.2020.11766733359353
    [Google Scholar]
71. HerrmannA.M. MeckelS. GounisM.J. KringeL. MotschallE. MüllingC. BoltzeJ. Large animals in neurointerventional research: A systematic review on models, techniques and their application in endovascular procedures for stroke, aneurysms and vascular malformations.J. Cereb. Blood Flow Metab.201939337539410.1177/0271678X1982744630732549
    [Google Scholar]
72. MarklundN. HilleredL. Animal modelling of traumatic brain injury in preclinical drug development: Where do we go from here?Br. J. Pharmacol.201116441207122910.1111/j.1476‑5381.2010.01163.x21175576
    [Google Scholar]
73. LovettM.L. NielandT.J.F. DingleY.T.L. KaplanD.L. Innovations in 3D tissue models of human brain physiology and diseases.Adv. Funct. Mater.20203044190914610.1002/adfm.20190914634211358
    [Google Scholar]
74. ArcherD.P. WalkerA.M. McCannS.K. MoserJ.J. AppireddyR.M. Anesthetic neuroprotection in experimental stroke in rodents: A systematic review and meta-analysis.Anesthesiology2017126465366510.1097/ALN.000000000000153428182585
    [Google Scholar]
75. CapitanioJ.P. EmborgM.E. Contributions of non-human primates to neuroscience research.Lancet200837196181126113510.1016/S0140‑6736(08)60489‑418374844
    [Google Scholar]
76. BusijaD.W. LaczaZ. RajapakseN. ShimizuK. KisB. BariF. DomokiF. HoriguchiT. Targeting mitochondrial ATP-sensitive potassium channels-a novel approach to neuroprotection.Brain Res. Brain Res. Rev.200446328229410.1016/j.brainresrev.2004.06.01115571770
    [Google Scholar]
77. StellaS.L.Jr GeathersJ.S. WeberS.R. GrilloM.A. BarberA.J. SundstromJ.M. GrilloS.L. Neurodegeneration, neuroprotection and regeneration in the zebrafish retina.Cells202110363310.3390/cells1003063333809186
    [Google Scholar]
78. PrasadhS. WongR.C.W. Unraveling the mechanical strength of biomaterials used as a bone scaffold in oral and maxillofacial defects.Oral Sci. Int.2018152485510.1016/S1348‑8643(18)30005‑3
    [Google Scholar]
79. AndersonJ.M. Biological responses to materials.Annu. Rev. Mater. Res.20013118111010.1146/annurev.matsci.31.1.81
    [Google Scholar]
80. OmidianH. BabanejadN. CubedduL.X. Nanosystems in cardiovascular medicine: Advancements, applications, and future perspectives.Pharmaceutics2023157193510.3390/pharmaceutics1507193537514121
    [Google Scholar]
81. PasupuletiM. MolahallyS. SalwajiS. Ethical guidelines, animal profile, various animal models used in periodontal research with alternatives and future perspectives.J. Indian Soc. Periodontol.201620436036810.4103/0972‑124X.18693128298815
    [Google Scholar]
82. SilbermanG. KahnK.L. Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.Milbank Q.201189459962710.1111/j.1468‑0009.2011.00644.x22188349
    [Google Scholar]
83. CoteD.J. BredenoordA.L. SmithT.R. AmmiratiM. BrennumJ. MendezI. AmmarA.S. BalakN. BollesG. EseneI.N. MathiesenT. BroekmanM.L. Ethical clinical translation of stem cell interventions for neurologic disease.Neurology201788332232810.1212/WNL.000000000000350627927932
    [Google Scholar]
84. FreedmanB.R. MooneyD.J. Biomaterials to mimic and heal connective tissues.Adv. Mater.20193119180669510.1002/adma.20180669530908806
    [Google Scholar]
85. FerreiraG.S. Veening-GriffioenD.H. BoonW.P.C. MoorsE.H.M. van MeerP.J.K. Levelling the translational gap for animal to human efficacy data.Animals2020107119910.3390/ani1007119932679706
    [Google Scholar]
86. LynchM.J. GobboO.L. Advances in non-animal testing approaches towards accelerated clinical translation of novel nanotheranostic therapeutics for central nervous system disorders.Nanomaterials20211110263210.3390/nano1110263234685073
    [Google Scholar]
87. ShepherdR.K. VillalobosJ. BurnsO. NayagamD.A.X. The development of neural stimulators: A review of preclinical safety and efficacy studies.J. Neural Eng.201815404100410.1088/1741‑2552/aac43c29756600
    [Google Scholar]